Fatigue News and Research

RSS

New Columbia University center provides specialized care for Lyme and tick-borne diseases

A new center that will provide specialized care for patients with Lyme disease and other tick-borne diseases will begin seeing patients this summer at Columbia University's Vagelos College of Physicians and Surgeons.

31 Mar 2021

Study compares performance of open-label placebo to blinded placebo in IBS patients

For decades, the power of the placebo effect was thought to lie in patients' belief that they were -- or at least, could be -- receiving a pharmacologically active treatment.

30 Mar 2021

First cell-based gene therapy approved by the FDA for treating multiple myeloma

The U.S. Food and Drug Administration approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy.

29 Mar 2021

Long-term complications are common among COVID-19 recovered individuals

A team of scientists from the United Kingdom has recently conducted a multicenter, prospective cohort study to investigate long-term consequences of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

24 Mar 2021

Survey of surge capacity managers captures pandemic preparedness status of the U.S. health care system

A University of Pittsburgh School of Medicine-led survey of dozens of surge capacity managers at hospitals nationwide captures the U.S. health care system's pandemic preparedness status in the months before the first COVID-19 cases were identified in China.

24 Mar 2021

New review of post-acute COVID-19

The first year of the COVID-19 pandemic has taken the lives of millions of people around the world but has also left hundreds with lingering symptoms or completely new symptoms weeks after recovery.

23 Mar 2021

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

Results from a large clinical trial in the United States and South America indicate that AstraZeneca's COVID-19 vaccine, AZD1222, is well-tolerated and protects against symptomatic COVID-19 disease, including severe disease or hospitalization.

22 Mar 2021

Can SARS-CoV-2 still be transmissible once symptoms have subsided?

Researchers based at the University of Missouri, in partnership with U.S. government science facilities in Maryland, have reported that individuals severely infected with SARS-CoV-2 may be able to continue shedding infectious viral RNA for over three weeks after the symptomatic infection has passed.

22 Mar 2021

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

CDI Labs – a biotechnology company based in Puerto Rico – is using INTEGRA’s VIAFLO and VOYAGER electronic pipettes to streamline workflows and improve accuracy for the development of next generation proteomics products.

From INTEGRA Biosciences 17 Mar 2021

Ferret study shows SARS-CoV-2 airborne transmission dynamics

A team of researchers led by Sander Herfst from Erasmus University Medical Center in The Netherlands suggests severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could spread through the air at a one-meter distance and cause infection in a new ferret model study.

16 Mar 2021

Study proves that postural orthostatic tachycardia syndrome may be an autoimmune disorder

The symptoms of postural orthostatic tachycardia syndrome, or POTS, can be as varied as they are confounding. There can be fatigue, pain, bleeding disorders and anxiety. Heart palpitations and lightheadedness are common.

16 Mar 2021

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

A new piece of research, published on the medRxiv preprint server, focused on the role of factors such as gender, age, hospitalization, etc., in understanding the risks of clinical sequelae in the post-acute phase of COVID-19, in adults aged between 18 and 65 years.

15 Mar 2021

Study of post-acute sequelae of SARS-CoV-2 infection shows persistent symptoms 8 months

Researchers from the US recently studied the prevalence of PASC in a well-characterized cohort of patients to gain insights into the period following acute SARS-CoV-2 infection. The research is posted online to the preprint server medRxiv.

15 Mar 2021

Researchers find no evidence to suggest a link between beta blockers and depression

Drugs such as beta-adrenergic antagonists (beta blockers) have been linked to a range of adverse effects, including depression.

15 Mar 2021

COVID-19 survivors experience symptoms up to 10 months after infection, study finds

Coronavirus disease (COVID-19) symptoms are increasingly recognized to persist among a subset of individuals following acute infection, but features associated with this persistence are not well-understood.

15 Mar 2021

AI-based assessment of of surgical skills

More than one million operations are performed in Switzerland every year. A surgeon's skill has a direct impact on the outcome of the operation.

13 Mar 2021

Vital exhaustion may increase risk of heart attack in never married, divorced and widowed men

Men experiencing vital exhaustion are more likely to have a heart attack, according to research presented today at ESC Acute CardioVascular Care 2021, an online scientific congress of the European Society of Cardiology.

13 Mar 2021

SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment, study finds

Researchers have found that SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment. Therefore, strategies such as focusing on limiting the production of IFN, rather than its function, could restrict the mechanism of SARS-CoV-2 that increases its viral load with delayed or absent symptoms.

12 Mar 2021

Researchers highlight the need to improve diagnosis, treatment of iron deficiency in women

A new article has highlighted the need to improve diagnosis and treatment of one of the most common conditions affecting women worldwide – iron deficiency.

11 Mar 2021

Researchers shed light on T-cell receptor activation in response to infection

Immune cells specialize to ensure the most efficient defense against viruses and other pathogens. Researchers at the University of Basel have shed light on this specialization of T cells and shown that it occurs differently in the context of an acute and a chronic infection.

10 Mar 2021

Fatigue News and Research

New Columbia University center provides specialized care for Lyme and tick-borne diseases

Study compares performance of open-label placebo to blinded placebo in IBS patients

First cell-based gene therapy approved by the FDA for treating multiple myeloma

Long-term complications are common among COVID-19 recovered individuals

Survey of surge capacity managers captures pandemic preparedness status of the U.S. health care system

New review of post-acute COVID-19

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

Can SARS-CoV-2 still be transmissible once symptoms have subsided?

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

Ferret study shows SARS-CoV-2 airborne transmission dynamics

Study proves that postural orthostatic tachycardia syndrome may be an autoimmune disorder

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

Study of post-acute sequelae of SARS-CoV-2 infection shows persistent symptoms 8 months

Researchers find no evidence to suggest a link between beta blockers and depression

COVID-19 survivors experience symptoms up to 10 months after infection, study finds

AI-based assessment of of surgical skills

Vital exhaustion may increase risk of heart attack in never married, divorced and widowed men

SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment, study finds

Researchers highlight the need to improve diagnosis, treatment of iron deficiency in women

Researchers shed light on T-cell receptor activation in response to infection

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News